Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study

Overview of attention for article published in Journal of Translational Medicine, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 57 X users
patent: 1 patent

facebook: 12 Facebook pages
wikipedia: 3 Wikipedia pages
googleplus: 3 Google+ users
reddit: 2 Redditors

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 85 Mendeley

Summary News Blogs Policy documents X Patents Facebook Wikipedia Google+ Reddit Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Inhibin subunit beta B (INHBB): an emerging role in tumor progression

Article in Journal of Physiology and Biochemistry (August 2024)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease

Article in Frontiers in Immunology (June 2024)

Establishment of reference intervals for plasma IL-2, IL-4, IL-5, and IL-17A in healthy adults from the Jiangsu region of eastern China using flow cytometry: A single-center study

Article in Cytokine (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.